FLT3 and IDH1/2 Inhibitors for Acute Myeloid Leukemia: Focused Clinical Narrative Review of Forthcoming Drugs from an Indian Context

FLT3 and IDH1/2 Inhibitors for Acute Myeloid Leukemia: Focused Clinical Narrative Review of Forthcoming Drugs from an Indian Context

Therapeutic approaches for acute myeloid leukemia (AML) have witnessed minimal evolution in recent decades, primarily relying on advancements in supportive care and transplantation to drive improvements in overall survival rates. However, treatment with intensive chemotherapy may not be feasible for...

Full description

Saved in:

Bibliographic Details
Main Authors:	Suvir Singh, Kunal Jain, Jagdeep Singh, Nitish Garg, Akriti Arora
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2024-04-01
Series:	Indian Journal of Medical and Paediatric Oncology
Subjects:	myeloid leukemia FLT3 midostaurin gilteritinib sorafenib
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1779621
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gilteritinib maintenance after allogeneic hematopoietic stem cell transplantation for relapsed/refractory acute myeloid leukemia with FLT3-internal tandem duplication mutation
by: Chen Liang, et al.
Published: (2025-12-01)

Salvage therapy containing sorafenib and donor lymphocyte infusion is associated with improved outcomes for FLT3 wild-type acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation
by: Zhonghui Jiang, et al.
Published: (2025-08-01)

Feasible and Rapid Screening of <i>IDH1/2</i> and <i>FLT3-TKD2</i> Mutations by High-Resolution Melting for Patients with Acute Myeloid Leukemia
by: José Vicente Gil, et al.
Published: (2025-05-01)

Mutations in the “hot spots” of the <i>FLT3</i>, <i>NPM1</i>, <i>IDH1</i>, <i>IDH2</i> and <i>DNMT3A</i> genes in acute myeloid leukemia
by: E. N. Voropaeva, et al.
Published: (2025-03-01)

Sitravatinib combined with venetoclax exerts effective synergy to eliminate acute myeloid leukemia cells with FLT3-ITD mutations
by: Jie Yang, et al.
Published: (2025-09-01)

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
by: Na Wang, et al.
Published: (2021-01-01)

Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia
by: Bai‐Liang He, et al.
Published: (2020-03-01)

The Role of Bosutinib in Chronic Myeloid Leukemia: An Indian Perspective
by: Mohan Bajranglal Agarwal, et al.
Published: (2024-08-01)

Acute Myeloid Leukemia With Extramedullary Infiltration‐Gastric Myeloid Sarcoma: A Case Report and Literature Review
by: Cong Ding, et al.
Published: (2025-07-01)

An unusual case of acute myeloid leukemia with t(8:21) presenting with hypereosinophilia showing dysplastic features
by: Pragya Singh, et al.
Published: (2020-01-01)

Serum sFlt-1/PlGF ratio combined with ANXA2 correlates with adverse pregnancy outcomes in women with suspected preeclampsia
by: YaNuan Chen, et al.
Published: (2025-12-01)

Acute myeloid leukemia presenting as an isolated orbital mass in an adult
by: Cindy S. Zhao, et al.
Published: (2025-09-01)

Iron overload promotes myeloid differentiation of normal hematopoietic stem cells and educates macrophage mediated immunosuppression in acute myeloid leukemia
by: Feifei Yang, et al.
Published: (2025-08-01)

Immunophenotypic investigation of infant acute myeloid leukemia
by: A. M. Popov, et al.
Published: (2014-07-01)

Acute Myeloid Leukemia with NUP98: : LNP1 Fusion Mimicking Chronic Myeloid Leukemia
by: Haiyang Wang, et al.
Published: (2025-06-01)

Polatuzumab Vedotin for Diffuse Large B-Cell Lymphoma: Innovation's Allure versus a Time-Honored Tradition
by: Suvir Singh, et al.
Published: (2024-12-01)

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia
by: E. G. Lomaia, et al.
Published: (2014-07-01)

Treatment of elderly patients with acute myeloid leukemia: personal experience
by: L. T. Shimanovskaya, et al.
Published: (2024-12-01)

Chronic myeloid leukemia in childhood: a case report
by: Uma Bhatta, et al.
Published: (2021-09-01)

Altered Oral Intake During Hematopoietic Stem Cell Transplantation: Patterns and Countermeasures
by: Suvir Singh, et al.
Published: (2021-07-01)

Chromosomal Anomalies in Acute Myeloid Leukemia: Cytogenetic Results of -417 Cases Froma Single Center
by: Nüket Yürür-Kutlay, et al.
Published: (2017-04-01)

Treatment results of pediatric acute myeloid leukemia with epigenetic drugs addition
by: V. S. Nemirovchenko, et al.
Published: (2020-07-01)

Granulomatous rosacea: Like leukemid in a patient with acute myeloid leukemia
by: Škiljević Dušan, et al.
Published: (2008-01-01)

Report of patients with chronic myeloid leukemia Kidwai Memorial Institute of Oncology, Bangalore over 15 years
by: Govind Babu
Published: (2013-01-01)

METABOLIC STATE OF BLOOD LYMPHOCYTES IN CHRONIC MYELOID LEUKEMIA AND CHRONIC LYMPHOID LEUKEMIA
by: O. V. Smirnova, et al.
Published: (2014-07-01)

Effect of ultrasound-microbubble exposure on acute myeloid leukemia cancer cell proteome
by: Joelle Stilwell, et al.
Published: (2025-08-01)

Machine learning approaches reveal methylation signatures associated with pediatric acute myeloid leukemia recurrence
by: Yushuang Dong, et al.
Published: (2025-05-01)

PAK4 phosphorylates and stabilizes MYC to promote acute myeloid leukemia
by: Ting Xie, et al.
Published: (2025-10-01)

Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia
by: Joan So, et al.
Published: (2022-05-01)

The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad
by: Sandip A Shah
Published: (2013-01-01)

Fatal Disseminated Mucormycosis by Cunninghamella in Newly Diagnosed Acute Myeloid Leukemia: Case Report and Diagnostic Challenges
by: Sebastián González-Valdés, et al.
Published: (2025-04-01)

Role of metabolomic changes in diagnosis and assessment of treatment response in acute myeloid leukemia
by: Shabbir Hussain, et al.
Published: (2025-08-01)

Genetic profile of ASXL1 gene in risk assessment in acute myeloid leukemia
by: Salem Ahmed Bamusa, et al.
Published: (2025-07-01)

Unlocking the Potential of Perillaldehyde: A Novel Mechanism for Chronic Myeloid Leukemia by Targeting HSP70
by: Miaomiao Zhang, et al.
Published: (2025-05-01)

Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline RET S891A Protooncogene Mutation: 7-year Follow-up with Successful Sorafenib Treatment
by: Sirmen Kızılcan Çetin, et al.
Published: (2025-09-01)

Successful two-stage operation for esophageal necrosis due to proton beam therapy followed by sorafenib in a case of large hepatocellular carcinoma
by: Eiji Higaki, et al.
Published: (2020-06-01)

Efficacy and safety of mitoxantrone hydrochloride liposome-containing regimens in treating refractory/relapsed acute myeloid leukemia
by: Ni Lu, et al.
Published: (2025-05-01)

Report of chronic myeloid leukemia in chronic phase from Cancer Institute (Women India Association), Chennai, 2002-2009
by: Prasanth Ganesan, et al.
Published: (2013-01-01)

Ferroptosis determinants – potential predictors and therapeutic targets for acute myeloid leukemia
by: V. E. Shevchenko, et al.
Published: (2025-06-01)

Identification of cell adhesion related signature for molecular subtyping and prognostic prediction in acute myeloid leukemia
by: Caifang Zhao, et al.
Published: (2025-07-01)